Pharmaceutical / Drug Definition :
Stimulates proliferation and differentiation of hematopoietic cells that activate mature granulocytes and macrophages of target cells
FDA Label Requirements and Exceptions
Sargramostim
FDA Import Information
Sargramostim
FDA Detentions
Sargramostim (Sargramostim Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Sargramostim (Sargramostim Suppliers)
- Processors Sargramostim
- Repackers Sargramostim
- Relabelers Sargramostim
- Exporters Sargramostim
- Importers Sargramostim
For more information about Sargramostim, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
